Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjoukje Lubberts

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|May 24, 2020
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to actSjoukje Lubberts, Coby Meijer, Marco Demaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2023
Reply to G. Wang et alSjoukje Lubberts, Flora E van Leeuwen, Michael Schaapveld, et al.
Scientific Reports|November 11, 2025
Changes in methylation associated with development of metabolic syndrome in testicular cancer patients treated with cisplatin chemotherapyMarcin W Wojewodzic, Ellen L D Volders, Coby Meijer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2016
Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patientsGabriela G F van der Schoot, Nico-Derk L Westerink, Sjoukje Lubberts, et al.
Urologic Oncology|December 5, 2023
Change in telomere length and cardiovascular risk factors in testicular cancer survivorsEllen L D Volders, Coby Meijer, Lotte S Steeneken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2023
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of LifeSjoukje Lubberts, Harmke J Groot, Ronald de Wit, et al.
The Oncologist|June 23, 2016
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis MarkersMartha W den Hollander, Nico-Derk L Westerink, Sjoukje Lubberts, et al.
British Journal of Cancer|September 14, 2020
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapyJohannes Stelwagen, Sjoukje Lubberts, Lars C Steggink, et al.
Cancers|November 27, 2021
Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after TreatmentJohannes Stelwagen, Andrea T Meuleman, Sjoukje Lubberts, et al.
Cancer|November 16, 2019
Platinum exposure and cause-specific mortality among patients with testicular cancerHarmke J Groot, Flora E van Leeuwen, Sjoukje Lubberts, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|May 24, 2020
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to actSjoukje Lubberts, Coby Meijer, Marco Demaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2023
Reply to G. Wang et alSjoukje Lubberts, Flora E van Leeuwen, Michael Schaapveld, et al.
Scientific Reports|November 11, 2025
Changes in methylation associated with development of metabolic syndrome in testicular cancer patients treated with cisplatin chemotherapyMarcin W Wojewodzic, Ellen L D Volders, Coby Meijer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2016
Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patientsGabriela G F van der Schoot, Nico-Derk L Westerink, Sjoukje Lubberts, et al.
Urologic Oncology|December 5, 2023
Change in telomere length and cardiovascular risk factors in testicular cancer survivorsEllen L D Volders, Coby Meijer, Lotte S Steeneken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2023
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of LifeSjoukje Lubberts, Harmke J Groot, Ronald de Wit, et al.
The Oncologist|June 23, 2016
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis MarkersMartha W den Hollander, Nico-Derk L Westerink, Sjoukje Lubberts, et al.
British Journal of Cancer|September 14, 2020
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapyJohannes Stelwagen, Sjoukje Lubberts, Lars C Steggink, et al.
Cancers|November 27, 2021
Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after TreatmentJohannes Stelwagen, Andrea T Meuleman, Sjoukje Lubberts, et al.
Cancer|November 16, 2019
Platinum exposure and cause-specific mortality among patients with testicular cancerHarmke J Groot, Flora E van Leeuwen, Sjoukje Lubberts, et al.
Pageof 2